Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick. - Wikidata - awgldk - TriplyDB

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

http://www.wikidata.org/entity/Q34465812

about

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe Ebola virus disease and critical illness.Clinical development of Ebola vaccines A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus Experimental Therapies for Ebola Virus Disease: What Have We Learned?Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine Ebola, the killer virus.Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa.Fighting Ebola: A Window for Vaccine Re-evaluation?Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy Development of experimental and early investigational drugs for the treatment of Ebola virus infections.A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.Ebola vaccines in clinical trial: The promising candidates.Ebola Virus Shedding and Transmission: Review of Current Evidence.Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus.Ebola virus encodes a miR-155 analog to regulate importin-α5 expression.Vaccines against 'the other' Ebolavirus species.Stability of a Vesicular Stomatitis Virus-Vectored Ebola Vaccine.From bench to almost bedside: the long road to a licensed Ebola virus vaccine.Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus.

P2860

Q24289281-3593FF61-5AE0-45A0-BF75-9BEF9DDA9E0C Q26250274-6EE820ED-6B07-4D9F-9849-0164D3BF34E0 Q26775792-F3D29F45-D5A2-4838-8499-8C8FC33E6102 Q30235073-1DF5B6D5-B4F9-4ECA-8F33-C0B7FF409A76 Q30275032-466B6817-0CB7-4D7C-98AB-4C075516342E Q33715773-9FC5C4F0-FDF8-45FE-9DDD-199B2853D22F Q34488551-1467E5DF-B75C-4478-9CFD-883457AC3B81 Q34531417-B7F6A8ED-EF22-4EC7-A2C0-052FB677B506 Q35368649-FBCCB103-A8A5-4A6B-9F8E-6C7FE92776CA Q35598919-DA2A8AFE-186F-4532-8612-8D08E65205F9 Q35719946-B9894E5E-0D7B-420B-8BDC-48937698A7B8 Q36247762-3D349E04-3743-4283-939F-9DBA342EE806 Q36403500-AEFF92B8-0C3D-4365-A02B-8472C4298B6A Q36928875-0B52060A-7B56-4CAF-BD45-789E749B7E05 Q38524949-F5E85BB3-6AF5-4ABD-BAC3-E20D5F84AE4E Q38730996-28D336B3-5EEA-4955-ADA1-06AD4411FE3C Q38808678-B2D08284-E4B9-4627-BEEE-14D8457F6403 Q38904658-466BAADB-04B4-482E-B34A-28DB18C2C8BA Q40093846-0447A0C1-9288-487D-AE81-F1C1EEBEBF42 Q40108305-FDD099F8-F4FC-4C58-874D-B8581449C701 Q40109156-9C1843CB-79EC-4F18-9754-D275306D7CE5 Q40112699-70DD035F-A760-4D63-AE5D-8FBE4F95668D Q40131125-7AE13945-3C4E-485A-B6F1-CC4D061F6CB4 Q44106264-D4713D22-4DE2-4958-B928-2CF8AC94C523 Q47557500-7892F2AD-1878-4363-8AE7-AB51214794F7

P2860

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.

http://www.wikidata.org/entity/Q34465812

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@ast

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@en

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@nl

type

label

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@ast

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@en

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@nl

prefLabel

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@ast

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@en

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@nl

P1433

Q34465812-EFD19C13-DBE5-4A33-B006-97D8A027774F

P1476

Q34465812-B3FE8CFA-CB87-4BD4-8ACA-F9DE9FAD7665

P2093

Q34465812-1DAC035E-050C-436B-AA38-11896492A82C

Q34465812-3899C150-5FFA-4677-91F4-C5263ACB1778

Q34465812-55C20827-D938-4AF5-BE1D-C2C1487EA53F

Q34465812-55EF1BFB-EA30-4348-8871-557215711F70

Q34465812-82C439D7-E8C1-468F-9069-637232C763E3

Q34465812-84069E55-2FC3-4E6C-AA38-E015D2277439

Q34465812-8D10118C-AC6E-44CD-90FD-9F5ACEE8E82A

Q34465812-AEE8FD5D-EFBC-4081-9036-812DD1BE225A

Q34465812-B628123D-1D9D-48D0-8232-A9D7DAAC4864

Q34465812-E699EA30-4893-45D8-95B1-60F4E16F1788

P2860

Q34465812-09E14352-F33C-4C18-95FC-038652DAF068

Q34465812-0D240D24-DFCA-4AC2-9C14-61588006ED45

Q34465812-0EA3A3CA-1CF2-4ABF-BBCE-828E2A299C60

Q34465812-1AF796A7-7415-4E91-8884-078D886A6D19

Q34465812-36E90B74-62A0-442D-97CB-E9851AAC495E

Q34465812-402CA8DB-0FDD-4E08-8570-829921D0EA86

Q34465812-4676DFC5-A08F-40A8-9E27-EECD4501A061

Q34465812-4C260703-CF48-4399-846A-BF1193187729

Q34465812-7166CC8F-377D-4103-9D0D-7E831EB1D9B5

Q34465812-75610D76-4603-482E-85A5-9E68D3F26150

P304

Q34465812-087AC694-6E64-436E-9B62-BF91BF5D7D50

P31

Q34465812-3220599F-8A62-4E5F-9BA4-11B3C80B8EFD

P356

Q34465812-7FBACADF-911D-4D31-B29B-628DA788DD5E

P407

Q34465812-7AC51595-3128-4A06-B51B-1D961AF5618A

P433

Q34465812-9CBEFD90-BB6F-4FDE-84E5-9763DFCA1BC5

P478

Q34465812-5AC27A73-0262-433E-B7DC-F5EA1F2F5FA2

P50

Q34465812-304E7918-6D6D-4C8A-8509-356D5B202CBF

Q34465812-651A4996-0CC2-41C1-898E-B98CE1627621

Q34465812-6949ADA4-9526-4CE4-B57B-4800BF7E1861

Q34465812-8F11875D-7B2E-41B7-92A4-F7584A3BC2A8

Q34465812-9A4341AE-4F91-4085-82A3-28EA2942DD9A

P577

Q34465812-2CF7133F-C3B0-442F-8735-F600A55A0179

P698

Q34465812-7F459F2B-3F3D-4E3B-B758-87E596CB6885

P921

Q34465812-187096FF-EB51-4AAC-B2DD-B414F9D61676

Q34465812-A78BB01D-C447-46A6-995C-BD79512E8BAD

Q34465812-F4B9A2D1-B9F4-469B-9E11-C96BC48E1042

P932

Q34465812-B14AD353-9D8E-4FE4-A177-59742817BD31

P356

P1433

Journal of the American Medical Association

P1476

Emergency postexposure vaccina ...... ola vaccine after needlestick.

@en

P2093

Allison Beck

http://www.w3.org/2001/XMLSchema#string

Anthony F Suffredini

http://www.w3.org/2001/XMLSchema#string

Charles J Link

http://www.w3.org/2001/XMLSchema#string

Judie Alimonti

http://www.w3.org/2001/XMLSchema#string

Lewis Rubinson

http://www.w3.org/2001/XMLSchema#string

Lilin Lai

http://www.w3.org/2001/XMLSchema#string

Mark J Mulligan

http://www.w3.org/2001/XMLSchema#string

Mark Wolcott

http://www.w3.org/2001/XMLSchema#string

Richard Davey

http://www.w3.org/2001/XMLSchema#string

Sarah Kabbani

http://www.w3.org/2001/XMLSchema#string

P2860

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

Effective post-exposure treatment of Ebola infection

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Ebola haemorrhagic fever in Zaire, 1976

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

P304

1249-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2015.1995

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

313

http://www.w3.org/2001/XMLSchema#string

P50

Gary P. Kobinger

H. Clifford Lane

Timothy M. Uyeki

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25742465

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

Vaccine against Ebola

P932

4874522

http://www.w3.org/2001/XMLSchema#string